Tivic Health’s CEO, Jennifer Ernst, to Present at Upcoming ThinkEquity Conference in New York City
20 October 2022 - 11:30PM
Business Wire
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health
technology company that develops and commercializes bioelectronic
medicine, today announced that the company’s CEO will present at
The ThinkEquity Conference to be held on Wednesday, October 26 in
New York City.
WHO:
Jennifer Ernst, Chief Executive Officer,
Tivic Health
WHAT:
The ThinkEquity Conference
WHERE:
The Mandarin Oriental Hotel, NYC
WHEN:
October 26, 2022
About Tivic Health
Tivic Health Systems, Inc. is a commercial-phase health
technology company delivering non-invasive bioelectronic treatments
that provide consumers with a choice in the treatment of
inflammation and certain other related conditions. For more
information visit https://tivichealth.com @TivicHealth.
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Additional information concerning Tivic Health and its business,
including a discussion of factors that could materially affect the
company operating results, is contained in the company’s Annual
Report on Form 10-K for the year ended December 31, 2021, filed
with the Securities and Exchange Commission on March 31, 2022,
under the heading “Risk Factors,” as well as the company’s
subsequent filings with the Securities and Exchange Commission.
Forward-looking statements contained in this press release are made
as of this date, and Tivic Health Systems, Inc. undertakes no duty
to update such information except as required by applicable
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221020005228/en/
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Media Contact: Tivic Health Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com 617-723-4004
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Apr 2024 to May 2024
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From May 2023 to May 2024